Abstract

BackgroundDNA methylation is an important epigenetic mechanism of transcriptional control that plays an essential role in several cellular functions. Aberrant DNA methylation in cancer has been frequently associated with downregulation of microRNAs and protein coding genes, such as miR-200c/miR-141 cluster and E-cadherin. Current strategies to assess DNA methylation, including bisulfite treatment-based assays, tend to be time-consuming and may be quite expensive when a precise appraisal is required. The Sanger-sequencing of the amplified bisulfite-treated DNA (BSP) might represent a practical option to measure DNA methylation at single CpG resolution. However, this strategy often produces noisy data, which affects accurate quantification. Here we propose an improved, reliable and cost-effective BSP-based protocol that allows proper DNA methylation assessment.MethodsOur strategy, named normalized-BSP (NBSP), takes advantage of tailed C-balanced primers and a normalization procedure based on C/T ratio to overcome BSP-associated noise problems and nucleotide signal unbalance. NBSP was applied to estimate miR-200c/miR-141 locus methylation in serial dilution experiments and was compared to conventional methods. Besides, it was applied in the analysis of FFPE breast cancer samples and further validated in the context of the E-cadherin promoter.ResultsNBSP strategy outperformed conventional BSP in the estimate of the fraction of methylated cytosine in serial dilution experiments, providing data in agreement with the widely used but cumbersome cloning-based protocol. This held true for both miR-200c/miR-141 locus and E-cadherin promoter analyses. Moreover, the miR-200c/miR-141 locus methylation reflected the decrease in miRNA expression both in breast cancer cell lines and in the FFPE samples.ConclusionsNBSP is a rapid and economical method to estimate the extent of methylation at each CpG of a given locus. Notably, NBSP works efficiently on FFPE samples, thus disclosing the perspective of its application also in the diagnostic setting.Electronic supplementary materialThe online version of this article (doi:10.1186/s12885-015-1646-6) contains supplementary material, which is available to authorized users.

Highlights

  • DNA methylation is an important epigenetic mechanism of transcriptional control that plays an essential role in several cellular functions

  • To adjust the overscaled C signals in the sequencing chromatograms we introduced a normalization factor (NF), based on the ratio of the signals for the C and T encoded by the tails of primers

  • We first performed the analysis of this region in a set of plasmid DNA standards obtained by mixing defined amount of clones corresponding to methylated and unmethylated DNA

Read more

Summary

Introduction

DNA methylation is an important epigenetic mechanism of transcriptional control that plays an essential role in several cellular functions. The Sangersequencing of the amplified bisulfite-treated DNA (BSP) might represent a practical option to measure DNA methylation at single CpG resolution. This strategy often produces noisy data, which affects accurate quantification. Several technologies have been developed to profile the methylation at CGI. These include comprehensive but expensive next-generation sequencing-based approaches Most techniques rely on the bisulfite conversion of unmethylated cytosine to uracil, and to thymine after PCR, leaving unaltered the methylated cytosine [13]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call